Showing 1 - 10 of 84
News, Poramet Tangsathaporn, Published on 06/02/2026
» Thailand's role as a key partner to the Nordic countries was reaffirmed at the Nordic Day reception jointly hosted by the Norwegian, Danish, Finnish, and Swedish embassies on Wednesday at the Norwegian Ambassador's Residence in Bangkok, ahead of Nordic Day on March 23.
Guru, Published on 05/12/2025
» Guru By Bangkok Post's pick of the most exciting products, activities, food and travel to indulge in.
News, Poramet Tangsathaporn, Published on 08/11/2025
» The Bangkok Metropolitan Administration (BMA), the Danish Embassy, and Novo Nordisk Pharma Thailand have signed a Memorandum of Understanding (MoU) to promote healthier urban lifestyles and combat obesity under the "Bangkok, City for Better Health" initiative.
Oped, Postbag, Published on 25/07/2025
» Re: "Thai airstrikes hit two Cambodian targets," (BP, July 24).
Published on 02/06/2025
» The rapid advancement of medical technology is playing a vital role in enhancing the health system and quality of life for individuals in Thailand. Clinical research is essential in facilitating the development of new medications, devices, and treatment methodologies for complex and rare diseases. Reports indicate that nations such as China, the United States, various African countries, and others in Asia are significantly increasing their investments in medical research and development (R&D). Thailand has been classified as an ‘opportunity tier’, possessing a large number of patients ready for treatment. This presents researchers with numerous opportunities for trial volunteers, making Thailand more competitive compared to Europe and the US, where research costs tend to be higher.
Published on 08/05/2025
» The Royal Danish Embassy in Thailand, in collaboration with Novo Nordisk Pharma (Thailand) Ltd. (“Novo Nordisk”), organised the first Danish-Thai Obesity Policy Forum, bringing together top policymakers, healthcare professionals and industry representatives to discuss challenges arising from the growing prevalence of obesity and its socio-economic impacts in Thailand. The forum, titled “Obesity – A National Threat to Health and Wealth, Act Now for Our Future Generations”, featured remarks from decision-makers and a panel discussion.
Business, Post Reporters, Published on 24/04/2025
» Green is the new luxury Mira Valley, a 50-billion-baht luxury residential project, spans 220 acres nestled in Phuket’s untouched forest, offering an exclusive, eco-conscious sanctuary for discerning buyers seeking luxury and sustainability.
News, Published on 08/02/2025
» Danish Ambassador to Thailand Danny Annan praised Novo Nordisk yesterday for its commitment to healthcare, innovation, and fostering stronger Thai-Danish relations as the two countries look to celebrate the 170th anniversary of fostering ties in 2028.
Published on 07/02/2025
» บริษัท โนโว นอร์ดิสค์ ฟาร์มา(ประเทศไทย) จำกัด จัดพิธีเปิดสำนักงานบริษัทฯ หลังจากการปรับปรุงขยายพื้นที่สำนักงาน เพื่อเพิ่มสมรรถนะในการสนับสนุนการทำงานของพนักงานและเพื่อรองรับจำนวนพนักงานที่เพิ่มขึ้นจากการขยายธุรกิจของบริษัทฯ ในประเทศไทย โดยมี นายเอนริโก้ คานัล บรูแลนด์ ผู้จัดการทั่วไปและ นายแดนนี แอนนัน เอกอัครราชทูตเดนมาร์ก ประจำประเทศไทย กล่าวเปิดงานPublished caption : Enrico Cañal Bruland, left, GM of Novo Nordisk Pharma Thailand, and Danish Ambassador Danny Annan cut the ribbon to mark the opening of the company’s newly renovated and enlarged office to support its business expansion in Thailand.
Published on 24/01/2025
» The Danish Embassy in Thailand, under the leadership of H.E. Mr. Danny Annan, Ambassador of Denmark to Thailand and Cambodia, hosted a pivotal session that marked a significant milestone in international healthcare collaboration. The event, following a visit by a Thai health delegation to Denmark from November 19-21, 2024, brought together key stakeholders to explore innovative strategies for diabetes management and public health transformation with eleven Thai government officials embarked on this journey with a clear mission: to explore cutting-edge diabetes management strategies, innovative health reimbursement models, and the potential of public-private partnerships in healthcare.